Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1990 Sep 15;301(6751):535–540. doi: 10.1136/bmj.301.6751.535

Renal replacement treatment for diabetic patients in Newcastle upon Tyne and the Northern region, 1964-88.

C Catalano 1, T H Goodship 1, J S Tapson 1, M K Venning 1, R M Taylor 1, G Proud 1, W M Tunbridge 1, R W Elliot 1, M K Ward 1, K G Alberti 1, et al.
PMCID: PMC1663834  PMID: 2207426

Abstract

OBJECTIVES--To review the experience of renal replacement treatment in diabetic patients treated in Newcastle upon Tyne and the Northern region from 1964 to 1988, and to compare the morbidity and mortality of diabetic patients treated with dialysis or transplantation with those of matched controls of non-diabetic patients. DESIGN--Retrospective study of clinical case notes. SETTING--Renal units of the Northern region, particularly that in Newcastle upon Tyne. PATIENTS--All 65 diabetic patients treated by renal replacement treatment in Newcastle upon Tyne from 1964 to 1987; 42 diabetic patients were matched with 42 non-diabetic patients according to age, sex, year of starting treatment, and type of treatment (dialysis or transplantation). MAIN OUTCOME MEASURES--Sex, age, renal biopsy findings, blood pressure, history of diabetic treatment, and plasma creatinine concentration at the start of renal replacement treatment. History of renal replacement treatments, suitability for transplantation, history of transplantation, cumulative survival, and cause of death during follow up. Survival of technique, cumulative survival of the first peritoneal catheter and history of peritonitis in patients treated with continuous ambulatory peritoneal dialysis; source of graft, histocompatibility antigens, duration of associated stay in hospital, and graft survival in patients receiving renal or pancreatic transplant. RESULTS--1259 Patients with chronic renal failure were accepted for renal replacement treatment in Newcastle upon Tyne, of whom 65 (5%) had diabetes. The first was accepted in 1974, and between 1974 and 1980 another 15 were treated (mean age 42 years; 4% of new patients). From 1981 to 1987, 49 diabetic patients (mean age 44; 9% of new patients) were treated. Fifty patients (77%) had insulin dependent diabetes and the remaining 15 (23%) non-insulin dependent diabetes. On average, the patients were aged 25 (range 5-57) when diabetes was first diagnosed and 44 (range 24-70) at the start of renal replacement treatment. The mean age at the start of treatment was 40 for patients with non-insulin dependent diabetes and 58 for patients with non-insulin dependent diabetes. Transplantation was performed in 33 of the diabetic patients, whose mean age was lower than that of those who did not receive a transplant (41 v 48 respectively, p less than 0.05). Comparison between the 42 diabetic patients and matched controls showed that the overall survival at five years was 46% and 77% respectively. The three year survival of the diabetic patients who did not receive a transplant was poor (41% v 79% respectively). Of patients transplanted, survival at five years was 73% in the diabetic patients and 90% in the controls. However, there was no significant difference in the five year graft survival (64% v 46% respectively). CONCLUSIONS--Diabetes adversely affects morbidity and mortality in patients having renal replacement treatment, but renal transplantation seems to be the best option for treating diabetic patients with end stage renal failure.

Full text

PDF
540

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amair P., Khanna R., Leibel B., Pierratos A., Vas S., Meema E., Blair G., Chisolm L., Vas M., Zingg W. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. N Engl J Med. 1982 Mar 18;306(11):625–630. doi: 10.1056/NEJM198203183061101. [DOI] [PubMed] [Google Scholar]
  2. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
  3. Berisa F., McGonigle R., Beaman M., Adu D., Michael J. The treatment of diabetic renal failure by continuous ambulatory peritoneal dialysis. Diabet Med. 1989 Jan-Feb;6(1):67–70. doi: 10.1111/j.1464-5491.1989.tb01142.x. [DOI] [PubMed] [Google Scholar]
  4. Brunner F. P., Brynger H., Challah S., Fassbinder W., Geerlings W., Selwood N. H., Tufveson G., Wing A. J. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant. 1988;3(5):585–595. doi: 10.1093/oxfordjournals.ndt.a091710. [DOI] [PubMed] [Google Scholar]
  5. Brunner F. P., Fassbinder W., Broyer M., Oulès R., Brynger H., Rizzoni G., Challah S., Selwood N. H., Dykes S. R., Wing A. J. Survival on renal replacement therapy: data from the EDTA Registry. Nephrol Dial Transplant. 1988;3(2):109–122. [PubMed] [Google Scholar]
  6. Chihara J., Takebayashi S., Taguchi T., Yokoyama K., Harada T., Naito S. Glomerulonephritis in diabetic patients and its effect on the prognosis. Nephron. 1986;43(1):45–49. doi: 10.1159/000183717. [DOI] [PubMed] [Google Scholar]
  7. Eggers P. W. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med. 1988 Jan 28;318(4):223–229. doi: 10.1056/NEJM198801283180406. [DOI] [PubMed] [Google Scholar]
  8. Ghavamian M., Gutch C. F., Kopp K. F., Kolff W. J. The sad truth about hemodialysis in diabetic nephropathy. JAMA. 1972 Dec 11;222(11):1386–1389. [PubMed] [Google Scholar]
  9. Grenfell A., Bewick M., Parsons V., Snowden S., Taube D., Watkins P. J. Non-insulin-dependent diabetes and renal replacement therapy. Diabet Med. 1988 Mar;5(2):172–176. doi: 10.1111/j.1464-5491.1988.tb00966.x. [DOI] [PubMed] [Google Scholar]
  10. Heaton A., Rodger R. S., Sellars L., Goodship T. H., Fletcher K., Nikolakakis N., Ward M. K., Wilkinson R., Kerr D. N. Continuous ambulatory peritoneal dialysis after the honeymoon: review of experience in Newcastle 1979-84. Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):938–941. doi: 10.1136/bmj.293.6552.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kasinath B. S., Mujais S. K., Spargo B. H., Katz A. I. Nondiabetic renal disease in patients with diabetes mellitus. Am J Med. 1983 Oct;75(4):613–617. doi: 10.1016/0002-9343(83)90442-4. [DOI] [PubMed] [Google Scholar]
  12. Kraus E. S., Spector D. A. Characteristics and sequelae of peritonitis in diabetics and nondiabetics receiving chronic intermittent peritoneal dialysis. Medicine (Baltimore) 1983 Jan;62(1):52–57. doi: 10.1097/00005792-198301000-00005. [DOI] [PubMed] [Google Scholar]
  13. Larsson O., Attman P. O., Aurell M., Frisk B., Brynger H. Survival in end-stage diabetic renal disease. A prospective study of 100 kidney transplant patients. Acta Med Scand. 1984;216(4):393–402. [PubMed] [Google Scholar]
  14. Legrain M., Rottembourg J., Bentchikou A., Poignet J. L., Issad B., Barthelemy A., Strippoli P., Gahl G. M., de Groc F. Dialysis treatment of insulin dependent diabetic patients: ten years experience. Clin Nephrol. 1984 Jan;21(1):72–81. [PubMed] [Google Scholar]
  15. Lynn K. L., Frendin T. J., Walker R. J., Bailey R. R., Swainson C. P. Renal disease in diabetics--which patients have diabetic nephropathy and what is their outcome? Aust N Z J Med. 1988 Oct;18(6):764–767. doi: 10.1111/j.1445-5994.1988.tb00176.x. [DOI] [PubMed] [Google Scholar]
  16. Mailloux L. U., Bellucci A. G., Mossey R. T., Napolitano B., Moore T., Wilkes B. M., Bluestone P. A. Predictors of survival in patients undergoing dialysis. Am J Med. 1988 May;84(5):855–862. doi: 10.1016/0002-9343(88)90063-0. [DOI] [PubMed] [Google Scholar]
  17. Manis T., Friedman E. A. Current thinking on the management of the uremic diabetic. Semin Nephrol. 1986 Jun;6(2):183–185. [PubMed] [Google Scholar]
  18. Matson M., Kjellstrand C. M. Long-term follow-up of 369 diabetic patients undergoing dialysis. Arch Intern Med. 1988 Mar;148(3):600–604. [PubMed] [Google Scholar]
  19. Moloney A., Tunbridge W. M., Ireland J. T., Watkins P. J. Mortality from diabetic nephropathy in the United Kingdom. Diabetologia. 1983 Jul;25(1):26–30. doi: 10.1007/BF00251892. [DOI] [PubMed] [Google Scholar]
  20. Passlick J., Grabensee B. CAPD and transplantation in diabetics. Clin Nephrol. 1988;30 (Suppl 1):S18–S23. [PubMed] [Google Scholar]
  21. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rosansky S. J., Eggers P. W. Trends in the US end-stage renal disease population: 1973-1983. Am J Kidney Dis. 1987 Feb;9(2):91–97. doi: 10.1016/s0272-6386(87)80085-9. [DOI] [PubMed] [Google Scholar]
  23. Teutsch S., Newman J., Eggers P. The problem of diabetic renal failure in the United States: an overview. Am J Kidney Dis. 1989 Jan;13(1):11–13. doi: 10.1016/s0272-6386(89)80106-4. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES